Stay updated on APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3 with no visible changes to study details or navigation.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2 and removed the previous government funding status notice (v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T13:59:36.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    - Notice about a lapse in government funding with guidance that the NIH Clinical Center is open and where to check status (opm.gov). - Revision: v3.4.1 added, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:16:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The glossary toggle was added, and a new 'Last Update Submitted that Met QC Criteria' field was introduced. The page revision was updated to v3.4.0 with capitalization changes to 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4 with no substantive changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:08.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, Massachusetts, New York, Pennsylvania, and Texas, and removed the HHS Vulnerability Disclosure link; page revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T09:22:47.000Z thumbnail image

Stay in the know with updates to APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M Combo in Metastatic Pancreatic Cancer Clinical Trial page.